Testing how well protein formulations can be injected using advanced technology.
Official title: High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators
Funded at Qatch Technologies, LLC · NIH-10916434 · Data updated 2026-11-12
This study is exploring a new technology that helps make protein-based treatments easier to develop and inject, which could lead to faster and more effective therapies for patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Qatch Technologies, LLC NIH-funded |
| Lab location | 1 site (Chapel Hill, UNITED STATES) |
| Project start | September 15, 2023 |
| Project end | September 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $886,907 |
| NIH project number | 5R44GM151918-02 |
| Project ID | NIH-10916434 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who may benefit from new protein-based therapies, particularly those requiring subcutaneous injections.
✕Less likely to help
Patients who do not require protein-based therapies or those who are not candidates for injectable treatments may not receive any benefit from this research.
What this research studies
This research focuses on improving the process of developing injectable protein-based therapeutics by utilizing a new technology called nanovisQ™. This device allows for high-throughput testing of the viscosity of protein formulations, which is crucial for ensuring they can be injected effectively. By automating the testing process and requiring less sample volume, this research aims to streamline the development of new treatments, making it faster and more cost-effective. Patients may benefit from more readily available and effective protein therapies as a result of this innovative approach.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient development of injectable protein therapies, improving treatment options for patients.
How similar studies have gone: Other research has shown promise in improving drug formulation testing methods, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
Qatch Technologies, LLC
Chapel Hill, United States Active
Researchers
- Principal investigator: Parlak, Zehra — Qatch Technologies, LLC
- Study coordinator: Parlak, Zehra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.